These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28007410)

  • 21. Assessment of recurrence of non-small cell lung cancer after therapy using CT and Integrated PET/CT.
    Opoka L; Szołkowska M; Podgajny Z; Kunikowska J; Barańska I; Błasińska-Przerwa K; Jakubowska L; Rudziński P; Bestry I; Roszkowski-Śliż K
    Pneumonol Alergol Pol; 2013; 81(3):214-20. PubMed ID: 23609428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does intensive follow-up alter outcome in patients with advanced lung cancer?
    Benamore R; Shepherd FA; Leighl N; Pintilie M; Patel M; Feld R; Herman S
    J Thorac Oncol; 2007 Apr; 2(4):273-81. PubMed ID: 17409797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer.
    Shimada Y; Suzuki K; Okada M; Nakayama H; Ito H; Mitsudomi T; Saji H; Takamochi K; Kudo Y; Hattori A; Mimae T; Aokage K; Nishii T; Tsuboi M; Ikeda N
    Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):895-901. PubMed ID: 27543652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
    Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
    Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in patterns of recurrence in early-stage versus locally advanced non-small cell lung cancer.
    Lou F; Sima CS; Rusch VW; Jones DR; Huang J
    Ann Thorac Surg; 2014 Nov; 98(5):1755-60; discussion 1760-1. PubMed ID: 25110337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Routine preoperative brain CT in resectable non-small cell lung cancer - Ten years experience from a tertiary UK thoracic center.
    Matys T; Drury R; David S; Rassl DM; Qian W; Rintoul RC; Screaton NJ
    Lung Cancer; 2018 Aug; 122():195-199. PubMed ID: 30032831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to surveillance guidelines in resected NSCLC: Physician compliance and impact on outcomes.
    Ho C; Siegfried J; Remo K; Laskin J
    Lung Cancer; 2017 Oct; 112():176-180. PubMed ID: 29191592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapy.
    Rwigema JC; Chen AM; Wang PC; Lee JM; Garon E; Lee P
    Clin Lung Cancer; 2014 Jul; 15(4):287-93. PubMed ID: 24594401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of anti-PD-1 therapy for recurrence after chemoradiotherapy in locally advanced NSC LC.
    Amino Y; Kitazono S; Uematsu S; Hasegawa T; Yoshizawa T; Uchibori K; Yanagitani N; Horiike A; Horai T; Kasahara K; Nishio M
    Int J Clin Oncol; 2020 Jan; 25(1):67-73. PubMed ID: 31506751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.
    Erb CT; Su KW; Soulos PR; Tanoue LT; Gross CP
    Lung Cancer; 2016 Sep; 99():200-7. PubMed ID: 27565940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
    Ebright MI; Russo GA; Gupta A; Subramaniam RM; Fernando HC; Kachnic LA
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):709-15. PubMed ID: 23317944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
    Chang JY; Verma V; Li M; Zhang W; Komaki R; Lu C; Allen PK; Liao Z; Welsh J; Lin SH; Gomez D; Jeter M; O'Reilly M; Zhu RX; Zhang X; Li H; Mohan R; Heymach JV; Vaporciyan AA; Hahn S; Cox JD
    JAMA Oncol; 2017 Aug; 3(8):e172032. PubMed ID: 28727865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?
    Yamaguchi M; Shimamatsu S; Edagawa M; Hirai F; Toyozawa R; Nosaki K; Seto T; Takenoyama M; Ichinose Y
    Surg Today; 2019 Mar; 49(3):197-205. PubMed ID: 30610361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of imaging surveillance for surgically treated early-stage lung cancer.
    Backhus LM; Farjah F; Zeliadt SB; Varghese TK; Cheng A; Kessler L; Au DH; Flum DR
    Ann Thorac Surg; 2014 Dec; 98(6):1944-51; discussion 1951-2. PubMed ID: 25282167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
    Hallqvist A; Wagenius G; Rylander H; Brodin O; Holmberg E; Lödén B; Ewers SB; Bergström S; Wichardt-Johansson G; Nilsson K; Ekberg L; Sederholm C; Nyman J
    Lung Cancer; 2011 Feb; 71(2):166-72. PubMed ID: 20541833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local control and survival following concomitant chemoradiotherapy in inoperable stage I non-small-cell lung cancer.
    Campeau MP; Herschtal A; Wheeler G; Mac Manus M; Wirth A; Michael M; Hogg A; Drummond E; Ball D
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1371-5. PubMed ID: 19250769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Relapse Events After Definitive Chemoradiotherapy in Locally Advanced Non-Small-Cell Lung Cancer Patients.
    Grass GD; Naghavi AO; Abuodeh YA; Perez BA; Dilling TJ
    Clin Lung Cancer; 2019 Jan; 20(1):e1-e7. PubMed ID: 30268836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salvage Surgery Post Definitive Chemoradiotherapy and Durvalumab for Lung Cancer.
    Minegishi K; Tsubochi H; Ohno K; Komori K; Ozeki M; Endo S
    Ann Thorac Surg; 2021 Jul; 112(1):e53-e55. PubMed ID: 33373589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.